Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): Roles for PACAP in anxiety-like behavior

Agarwal, 2005, Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene, Brain Res. Mol. Brain Res., 138, 45, 10.1016/j.molbrainres.2005.03.016 Arimura, 1998, Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems, Jpn. J. Physiol., 48, 301, 10.2170/jjphysiol.48.301 Braas, 1999, Pituitary adenylate cyclase-activating polypeptides directly stimulate sympathetic neuron neuropeptide Y release through PAC(1) receptor isoform activation of specific intracellular signaling pathways, J. Biol. Chem., 274, 27702, 10.1074/jbc.274.39.27702 Braas, 2007, Microarray analyses of pituitary adenylate cyclase activating polypeptide (PACAP)-regulated gene targets in sympathetic neurons, Peptides, 28, 1856, 10.1016/j.peptides.2007.04.004 Casada, 1991, Restraint and stimulation of bed nucleus of the stria terminalis produce similar stress-like behaviors, Brain Res. Bull., 27, 207, 10.1016/0361-9230(91)90069-V Commons, 2003, A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders, Neuropsychopharmacology, 28, 206, 10.1038/sj.npp.1300045 Dong, 2001, Topography of projections from amygdala to bed nuclei of the stria terminalis, Brain Res. Brain Res. Rev., 38, 192, 10.1016/S0165-0173(01)00079-0 Falluel-Morel, 2005, Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling, Proc. Natl. Acad. Sci. U.S.A., 102, 2637, 10.1073/pnas.0409681102 Girard, 2006, Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice, J. Neurochem., 99, 499, 10.1111/j.1471-4159.2006.04112.x Girard, 2002, Regulation of neurotrophic peptide expression in sympathetic neurons: quantitative analysis using radioimmunoassay and real-time quantitative polymerase chain reaction, Regul. Pept., 109, 89, 10.1016/S0167-0115(02)00191-X Gonzalez, 1997, Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts, Neuroscience, 78, 419, 10.1016/S0306-4522(96)00617-3 Hammack, 2004, Chemical lesion of the bed nucleus of the stria terminalis blocks the behavioral consequences of uncontrollable stress, Behav. Neurosci., 118, 443, 10.1037/0735-7044.118.2.443 Hannibal, 2002, Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study, J. Comp. Neurol., 453, 389, 10.1002/cne.10418 Hannibal, 1995, Pituitary adenylate cyclase-activating peptide gene expression in corticotropin-releasing factor-containing parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by colchicine, but not by adrenalectomy, acute osmotic, ether, or restraint stress, Endocrinology, 136, 4116, 10.1210/en.136.9.4116 Hashimoto, 1996, Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: an in situ hybridization study, J. Comp. Neurol., 371, 567, 10.1002/(SICI)1096-9861(19960805)371:4<567::AID-CNE6>3.0.CO;2-2 Hashimoto, 2001, Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP), Proc. Natl. Acad. Sci. U.S.A., 98, 13355, 10.1073/pnas.231094498 Herman, 2005, Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 29, 1201, 10.1016/j.pnpbp.2005.08.006 Jaworski, 2000, Developmental regulation of pituitary adenylate cyclase-activating polypeptide and PAC(1) receptor mRNA expression in the rat central nervous system, Brain Res. Dev. Brain Res., 120, 27, 10.1016/S0165-3806(99)00192-3 Kozicz, 1997, Axon terminals containing PACAP- and VIP-immunoreactivity form synapses with CRF-immunoreactive neurons in the dorsolateral division of the bed nucleus of the stria terminalis in the rat, Brain Res., 767, 109, 10.1016/S0006-8993(97)00737-3 Kozicz, 1998, The source of origin of PACAP- and VIP-immunoreactive fibers in the laterodorsal division of the bed nucleus of the stria terminalis in the rat, Brain Res., 810, 211, 10.1016/S0006-8993(98)00692-1 Lee, 1997, Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex, J. Neurosci., 17, 6434, 10.1523/JNEUROSCI.17-16-06434.1997 Legradi, 1998, Pituitary adenylate cyclase-activating polypeptide-nerve terminals densely innervate corticotropin-releasing hormone-neurons in the hypothalamic paraventricular nucleus of the rat, Neurosci. Lett., 246, 145, 10.1016/S0304-3940(98)00255-9 Lioudyno, 1998, Pituitary adenylate cyclase-activating polypeptide (PACAP) protects dorsal root ganglion neurons from death and induces calcitonin gene-related peptide (CGRP) immunoreactivity in vitro, J. Neurosci. Res., 51, 243, 10.1002/(SICI)1097-4547(19980115)51:2<243::AID-JNR13>3.0.CO;2-9 Lowry, 2005, Modulation of anxiety circuits by serotonergic systems, Stress, 8, 233, 10.1080/10253890500492787 Lu, 1997, Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells, Proc. Natl. Acad. Sci. U.S.A., 94, 3357, 10.1073/pnas.94.7.3357 Maier, 1993, The role of the amygdala and dorsal raphe nucleus in mediating the behavioral consequences of inescapable shock, Behav. Neurosci., 107, 377, 10.1037/0735-7044.107.2.377 Martinowich, 2007, New insights into BDNF function in depression and anxiety, Nat. Neurosci., 10, 1089, 10.1038/nn1971 Nicot, 2004, Altered social behavior in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice, J. Neurosci., 24, 8786, 10.1523/JNEUROSCI.1910-04.2004 Nielsen, 2004, PACAP promotes sensory neuron differentiation: blockade by neurotrophic factors, Mol. Cell. Neurosci., 25, 629, 10.1016/j.mcn.2003.12.004 Norrholm, 2005, Behavioral effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN), Regul. Pept., 128, 33, 10.1016/j.regpep.2004.12.023 Otto, 2001, Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice, J. Neurosci., 21, 5520, 10.1523/JNEUROSCI.21-15-05520.2001 Otto, 2001, Altered emotional behavior in PACAP-type-I-receptor-deficient mice, Brain Res. Mol. Brain Res., 92, 78, 10.1016/S0169-328X(01)00153-X Pego, 2008, Dissociation of the morphological correlates of stress-induced anxiety and fear, Eur. J. Neurosci., 27, 1503, 10.1111/j.1460-9568.2008.06112.x Phelix, 1992, Serotonin-CRF interaction in the bed nucleus of the stria terminalis: a light microscopic double-label immunocytochemical analysis, Brain Res. Bull., 28, 943, 10.1016/0361-9230(92)90217-L Sauvage, 2000, Mild deficits in mice lacking pituitary adenylate cyclase-activating polypeptide receptor type 1 (PAC1) performing on memory tasks, Brain Res. Mol. Brain Res., 84, 79, 10.1016/S0169-328X(00)00219-9 Schulkin, 1998, Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load, Psychoneuroendocrinology, 23, 219, 10.1016/S0306-4530(97)00099-1 Sherwood, 2000, The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily, Endocr. Rev., 21, 619, 10.1210/er.21.6.619 Singewald, 2003, Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs, Biol. Psychiatry, 53, 275, 10.1016/S0006-3223(02)01574-3 Stout, 2000, Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats, Eur. J. Pharmacol., 401, 39, 10.1016/S0014-2999(00)00412-X Straube, 2007, Waiting for spiders: brain activation during anticipatory anxiety in spider phobics, Neuroimage, 37, 1427, 10.1016/j.neuroimage.2007.06.023 Vaudry, 2000, Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions, Pharmacol. Rev., 52, 269 Vyas, 2003, Effects of chronic stress on dendritic arborization in the central and extended amygdala, Brain Res., 965, 290, 10.1016/S0006-8993(02)04162-8 Walker, 1997, Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear, J. Neurosci., 17, 9375, 10.1523/JNEUROSCI.17-23-09375.1997 Walker, 2002, Light enhanced startle: further pharmacological and behavioral characterization, Psychopharmacology, 159, 304, 10.1007/s002130100913 Walker, 2003, Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety, Eur. J. Pharmacol., 463, 199, 10.1016/S0014-2999(03)01282-2 Wolf, 1995, Phenotypic development of neonatal rat chromaffin cells in response to adrenal growth factors and glucocorticoids: focus on pituitary adenylate cyclase activating polypeptide, Neurosci. Lett., 200, 207, 10.1016/0304-3940(95)12116-L Yaka, 2003, Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N-methyl-D-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1, J. Biol. Chem., 278, 9630, 10.1074/jbc.M209141200